SUPPORT AND RESOURCES: HCP AND PATIENT RESOURCES
REBLOZYL resources
Clinical expert videos
Using sEPO ≤200 as a parameter in the LR-MDS treatment algorithm
George Yaghmour, MD
USC Norris Comprehensive Cancer Center & Hospital
Los Angeles, CA
Clinical response and duration in the RS-subgroups
Jamie Koprivnikar, MD
John Theurer Cancer Center Hackensack University Medical Center
Hackensack, NJ
Resources for healthcare providers
REBLOZYL First-line Clinical Data
View this summary of data regarding REBLOZYL as a first-line treatment for MDS–associated anemia.
Importance of Hemoglobin Brochure
Learn more about the impact of hemoglobin levels on patients with LR-MDS.
ESA Limitations Flashcard
Explore data highlighting unmet need for 1L MDS patients due to the limitations of ESAs and how REBLOZYL can help as a first-line treatment for patients with MDS–associated anemia.
MDS First-line Dosing Guide
Clear and detailed guidance on dosing REBLOZYL to optimize response in first-line patients with MDS–associated anemia.
MDS Reconstitution Guide
How to dose and administer REBLOZYL for your first-line patients with MDS–associated anemia.
Beta-thalassemia Dosing Flashcard
Clear and detailed guidance on dosing REBLOZYL to optimize response in patients with beta-thalassemia.
Resources for patients and caregivers
REBLOZYL MDS Patient Brochure
A guide for patients living with MDS-RS–associated anemia to learn more about REBLOZYL.
MDS Education Brochure
Give this brochure to your patients and caregivers so they can learn more about MDS, MDS–associated anemia, and support for people living with MDS.
MDS Patient Website
An information-filled resource where MDS patients can sign up for information about REBLOZYL.
REBLOZYL Treatment Tracker
A tool to help you track your transfusions and communicate your symptoms to your healthcare team.
REBLOZYL Beta-thalassemia Patient Brochure
A guide for patients living with beta-thalassemia–associated anemia to learn more about REBLOZYL.
Beta-thalassemia Patient Website
An information-filled resource where patients with beta-thalassemia can sign up for information about REBLOZYL.
EMR guidance resources
These EMR system resources can be used to identify patients along the REBLOZYL treatment journey. They provide instructions for creating lists or alerts to identify MDS patients who might be good candidates for REBLOZYL or patients who are currently on REBLOZYL who may require a dose adjustment. Instructions below are for the following EMR systems: Epic, Cerner, OncEMR, iKnowMed, Agnostic, and AllScripts.
Epic
Patient Identification Resources
Instructions for creating a list of patients who may be a good fit for REBLOZYL.
Instructions for creating an alert to identify patients who may be a good fit for REBLOZYL.
Dosing Resources
Instructions for creating a list of REBLOZYL patients who may be appropriate for a dose adjustment.
Instructions for creating an alert to identify REBLOZYL patients who may be appropriate for a dose adjustment.
Order Set Instructions
Instructions for creating an order set for REBLOZYL.
Cerner
Patient Identification Resources
Instructions for creating a list of patients who may be a good fit for REBLOZYL.
Instructions for creating an alert to identify patients who may be a good fit for REBLOZYL.
Dosing Resources
Instructions for creating a list of REBLOZYL patients who may be appropriate for a dose adjustment.
Instructions for creating an alert to identify REBLOZYL patients who may be appropriate for a dose adjustment.
Order Set Instructions
Instructions for creating an order set for REBLOZYL.
OncoEMR
Patient Identification Resources
Instructions for creating a list of patients who may be a good fit for REBLOZYL.
Instructions for creating an alert to identify patients who may be a good fit for REBLOZYL.
Dosing Resources
Instructions for creating a list of REBLOZYL patients who may be appropriate for a dose adjustment.
Instructions for creating an alert to identify REBLOZYL patients who may be appropriate for a dose adjustment.
Order Set Instructions
Instructions for creating an order set for REBLOZYL.
iKnowMed
Patient Identification Resources
Instructions for creating a list of patients who may be a good fit for REBLOZYL.
Instructions for creating an alert to identify patients who may be a good fit for REBLOZYL.
Dosing Resources
Instructions for creating a list of REBLOZYL patients who may be appropriate for a dose adjustment.
Instructions for creating an alert to identify REBLOZYL patients who may be appropriate for a dose adjustment.
Agnostic
Patient Identification Resources
Instructions for creating a list of patients who may be a good fit for REBLOZYL.
Instructions for creating an alert to identify patients who may be a good fit for REBLOZYL.
Dosing Resources
Instructions for creating a list of REBLOZYL patients who may be appropriate for a dose adjustment.
Instructions for creating an alert to identify REBLOZYL patients who may be appropriate for a dose adjustment.
Order Set Instructions
Instructions for creating an order set for REBLOZYL.
AllScripts
Order Set Instructions
Instructions for creating an order set for REBLOZYL.
ESA=erythropoiesis-stimulating agent; LR-MDS=lower-risk myelodysplastic syndromes; MDS=myelodysplastic syndromes; RS=ring sideroblast; sEPO=serum erythropoietin.